🔎 Trials Near Me

መነሻ › የፓንክሪያስ ካንሰር › Texas › San Antonio

በSan Antonio፣ TX ለየፓንክሪያስ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየፓንክሪያስ ካንሰር የሚደረጉ 31 ጥናቶች በSan Antonio እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, San Antonio
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05417594

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Texas Oncology - San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07562152

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • South Texas Accelerated Research Therapeutics (START), San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • NEXT Oncology, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • PHN-012-001 Site, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07127874

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Investigative Site US080, San Antonio
  • Investigative Site US063, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07522073

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • NEXT Oncology San Antonio, San Antonio
  • START Texas, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • NEXT, San Antonio
  • START - San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07349537

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Children's Hospital of San Antonio, San Antonio
እስከ እድሜ 17 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06651580

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • NEXT Oncology, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06440005

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • START- San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07644559

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • South Texas Accelerated Research Therapeutics, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05245500

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • START San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT06582017

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Texas Health Science Center at San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT06958328

IDOV-Immune for Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • South Texas Accelerated Research Therapeutics, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06910657

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • New Experimental Therapeutics of San Antonio LLC, San Antonio
  • START - South Texas Accelerated Research Therapeutics, LLC, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT07300150

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • NEXT Oncology, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT07458347

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • NEXT Oncology /ID# 243007, San Antonio
  • South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT05005403

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Research Site #2, San Antonio
  • Research Site, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • START, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • NEXT Oncology, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሜይ 2026 · NCT07223047

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Next Oncology, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT05379985

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • NEXT Oncology, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT06239194

A Study of MGC028 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT06723236

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • NEXT Oncology, San Antonio
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኤፕሪ 2026 · NCT06385925

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
  • UT Health San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT06244771

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • START San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ፌብሩ 2026 · NCT07030257

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ohio State University-Telemedicine, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2026 · NCT06906562

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • START San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2026 · NCT07145255

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Next Oncology, San Antonio, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጃንዩ 2026 · NCT07148128

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Exelixis Clinical Site #3, San Antonio
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሴፕቴ 2025 · NCT05932862

በሌሎች ከተሞች ለየፓንክሪያስ ካንሰር የሚደረጉ ጥናቶች

በSan Antonio ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።